Celebrex (Generic Celecoxib 200mg)
Clinical guidance, bioequivalence criteria, and verified partner dispensing standards for Celebrex (Generic Celecoxib 200mg). Reviewed by board-certified internal medicine and clinical pharmacotherapy specialists.
📖 Peer-Reviewed Clinical Monograph1. Pharmacological Profile & Executive Summary
Targeted COX-2 inhibitor that relieves arthritis, joint pain, and musculoskeletal inflammation with over 50% fewer gastrointestinal ulcers compared to non-selective NSAIDs.
Rheumatology & Internal Therapeutics • Celebrex (Generic Celecoxib 200mg)
2. Human Pharmacokinetic Matrix
| Pharmacokinetic Parameter | Clinical Metric | Therapeutic Significance |
|---|---|---|
| Peak Plasma Time (Tmax) | 3.0 hours (delayed slightly by high-fat meals) | Determines latency from ingestion to peak pharmacological onset. |
| Elimination Half-Life (T½) | 11.0 hours | Governs duration of action and steady-state dosing intervals. |
| Peak Concentration (Cmax) | 705 ng/mL (200mg) | Maximum observed systemic concentration in human plasma. |
| Bioavailability & Food Interaction | High | Defines oral bioavailability and dietary lipid dependency. |
| Plasma Protein Binding | 97% bound to plasma albumin | Governs free circulating drug fraction available for receptor binding. |
| Volume of Distribution (Vd) | 400 Liters | Reflects tissue and lipid compartment penetration. |
| Hepatic Metabolism | Hepatic CYP2C9 (major) to inactive carboxylate metabolites | Primary enzymatic clearance and CYP pathways. |
| Elimination / Excretion | 57% feces, 27% urine | Renal vs biliary/fecal excretion balance. |
3. Evidence-Based Clinical Dosing Protocols
Daily / Baseline Regimen
Osteoarthritis: 200 mg once daily (or 100 mg twice daily). Rheumatoid Arthritis & Ankylosing Spondylitis: 100 mg to 200 mg twice daily.
On-Demand / Titration Regimen
Acute Musculoskeletal Pain: 400 mg initial dose, followed by 200 mg PRN on subsequent days.
Hepatic Impairment (Child-Pugh B): reduce daily dose by 50%. Contraindicated in severe renal failure.
4. Pharmacokinetic Drug-Drug Interaction Matrix
| Interacting Agent / Class | Severity Tier | Clinical Mechanism & Management Strategy |
|---|---|---|
| Fluconazole / CYP2C9 Inhibitors | Major Precaution | Fluconazole doubles celecoxib plasma concentration; cut celecoxib dose in half. |
| ACE Inhibitors / ARBs / Diuretics | Moderate Precaution | May diminish antihypertensive response and elevate renal strain. |
5. Adverse Reaction Profile & Clinical Incidence Rates
| Adverse Reaction | Incidence Rate | Physiological Mechanism & Mitigation Strategy |
|---|---|---|
| Dyspepsia / Abdominal Pain | 8% | Significantly lower than ibuprofen or naproxen. |
| Peripheral Edema | 3% | Fluid retention in hypertensive patients. |
6. Patient Administration & Safe Usage Guidelines
Contraindicated in patients with severe sulfonamide (sulfa) allergy or aspirin-exacerbated respiratory disease. Take with food.
7. Frequently Asked Clinical Questions
Why is Celebrex safer for the stomach than Ibuprofen or Naproxen?
Standard NSAIDs block both COX-1 (protective stomach lining enzyme) and COX-2. Celecoxib selectively blocks COX-2 (inflammatory enzyme), preserving gastric mucosal protection.
Can Celebrex be taken with daily low-dose Aspirin?
Yes, but co-administration removes the GI-sparing advantage of celecoxib, increasing ulcer risk to that of standard NSAIDs.
Verified Telehealth Access Standards for Celebrex (Generic Celecoxib 200mg)
Our clinical editorial board audits certified partner telehealth dispensaries to guarantee authentic WHO-GMP manufacturing, analytical batch testing, and physician-supervised asynchronous consultation.
Peer-Reviewed Scientific Citations & FDA References
- Silverstein FE, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs (CLASS study). JAMA. 2000;284(10):1247-1255.